VanEck Biotech ETF (NASDAQ:BBH) Short Interest Up 521.1% in June

VanEck Biotech ETF (NASDAQ:BBHGet Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 11,800 shares, a growth of 521.1% from the May 31st total of 1,900 shares. Based on an average daily trading volume, of 7,700 shares, the short-interest ratio is presently 1.5 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in BBH. Kestra Advisory Services LLC increased its stake in shares of VanEck Biotech ETF by 16.1% during the 3rd quarter. Kestra Advisory Services LLC now owns 3,061 shares of the company’s stock valued at $477,000 after acquiring an additional 424 shares during the last quarter. Envestnet Asset Management Inc. increased its position in VanEck Biotech ETF by 2.9% during the 3rd quarter. Envestnet Asset Management Inc. now owns 21,949 shares of the company’s stock worth $3,418,000 after purchasing an additional 609 shares in the last quarter. Anchor Investment Management LLC acquired a new stake in VanEck Biotech ETF during the 4th quarter worth approximately $26,000. Raymond James Financial Services Advisors Inc. increased its position in VanEck Biotech ETF by 34.5% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 19,129 shares of the company’s stock worth $3,162,000 after purchasing an additional 4,909 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new stake in VanEck Biotech ETF during the 4th quarter worth approximately $305,000. 32.05% of the stock is currently owned by hedge funds and other institutional investors.

VanEck Biotech ETF Price Performance

NASDAQ:BBH traded down $1.55 on Friday, reaching $168.46. The stock had a trading volume of 6,035 shares, compared to its average volume of 7,986. The firm’s fifty day moving average is $164.85 and its two-hundred day moving average is $164.35. VanEck Biotech ETF has a 12-month low of $142.51 and a 12-month high of $173.49.

About VanEck Biotech ETF

(Get Free Report)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

Recommended Stories

Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.